Product introduction
StayHappi Darifenacin 7.5mg Tablet is a muscarinic antagonist that is used in the treatment of overactive bladder. It relieves urinary symptoms like frequent urination, urgent need to urinate, and inability to control urination.
StayHappi Darifenacin 7.5mg Tablet is advised to take it in a dose and duration as per prescription. It can be taken with or without food. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.
Some of the common side effects of this medicine are constipation, headache, dry mouth, urinary tract infection, nausea, and nasal dryness. If any of the side effects bother you or persist, consult the doctor without delay. They may be able to suggest ways to prevent or reduce the side effects.
Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you are pregnant or breastfeeding, tell your doctor prior to the treatment. This medicine is not recommended for people with severe liver disease must. Consult your doctor before using the medicine.
Benefits of StayHappi Tablet
Side effects of StayHappi Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of StayHappi
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use StayHappi Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. StayHappi Darifenacin 7.5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
How StayHappi Tablet works
StayHappi Darifenacin 7.5mg Tablet is an antimuscarinic. It works by relaxing muscles of the urinary bladder to prevent frequent, urgent or uncontrolled urination.
Safety advice
AlcoholCONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with StayHappi Darifenacin 7.5mg Tablet. Please consult your doctor.
PregnancyCONSULT YOUR DOCTOR
StayHappi Darifenacin 7.5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feedingCONSULT YOUR DOCTOR
StayHappi Darifenacin 7.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
StayHappi Darifenacin 7.5mg Tablet may cause side effects which could affect your ability to drive.
StayHappi Darifenacin 7.5mg Tablet may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness. This may affect your driving ability.
StayHappi Darifenacin 7.5mg Tablet is safe to use in patients with kidney disease. No dose adjustment of StayHappi Darifenacin 7.5mg Tablet is recommended.
However, inform your doctor if you have any underlying kidney disease.
StayHappi Darifenacin 7.5mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of StayHappi Darifenacin 7.5mg Tablet may be needed. Please consult your doctor.
What if you forget to take StayHappi Tablet?
If you miss a dose of StayHappi Darifenacin 7.5mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
StayHappi Darifenacin 7.5mg Tablet
₹11.6/Tablet
₹28.9/tablet
149% costlier
Fact Box
Chemical Class
Diphenylmethane Derivative
Action Class
Selective M3 anticholinergic (Bladder)
Interaction with drugs
Taking StayHappi with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Mifepristone may raise blood levels of Darifenacin.
If concurrent use is essential, watch out for symptoms of Darifenacin side effects such as constipation, dry mouth, headache, d... More
Concurrent use may increase the risk of intestinal obstruction.
watch out for symptoms such as dry mouth, increased heart rate, urination difficulties, constipation, loss of appet... More
Darifenacin may reduce blood levels of Digoxin.
If concurrent use is essential, your doctor may monitor your treatment and adjust the doses as per the observations.
Concurrent use may cause dry mouth, blurred vision, urinary retention, constipation, and confusion.
Talk to your doctor if you notice any unusual symptoms.
Concurrent use may cause dry mouth, blurred vision, urinary retention, constipation, and confusion.
Talk to your doctor if you notice any unusual symptoms.
Patient concerns
Urine leakage, overactive bladder
Dr. Deepak Kumar Soni
Ayurveda
Hi kindly share details history & reports
Overactive bladder having frequent urination. Cannot control urge of urine.
Dr. Deepak Kumar Soni
Ayurveda
https://goo.gl/forms/5QhDt8ZurRhhcjvD2 Kindly fill the health information so that I can advice best products to you thanks
Overactive urinary bladder is my problem. But I'd like to change the medication because of side effects from the present drug I'm using.
Dr. Aanchal Maheshwari
Ayurveda
Take mahayograj guggul 2 tab twice, chandraprabha vati 2 tablet twice with water. Do Yoga and pranayam
User feedback
What are you using StayHappi Tablet for?*Overactive bladder (OAB) symptoms
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 359.
Darifenacin. Luxembou: Merus Labs Luxco II S.à R.L; 2004 [revised 12 Jan. 2015]. [Accessed 04 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
Darifenacin [Prescribing Information]. Stein, Switzerland: Novartis Pharma Stein AG; 2012. [Accessed 06 Apr. 2024] (online) Available from:
Marketer details
Name: Sarvagunaushdhi Pvt Ltd
Address: 13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN